Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-667-6 | CAS number: 26402-22-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral (read-across OECD 423): LD50 > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- key study
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Source: CAS 91052-13-0
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- The read-across application is justified in the analogue justification. Based on the available data, the target and source substances are considered not to show differences in acute oral toxicity. The LD50 oral was > 2000 mg/kg bw for all source substances; therefore the target substance is expected to show a very low level of acute oral toxicity.
Reference
Additional data are available on the following source substances:
CAS 142-18-7:
LD50 (m/f, rat) > 20000 mg/kg bw
CAS 73398-61-5:
LD50 (f, mouse) > 23625 mg/kg bw
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The available information comprises adequate, reliable (Klimisch score 1 and 2) and consistent studies from reference substances with similar structure and intrinsic properties. Read-across is justified based on common precursors and breakdown products of hydrolysis and consistent trends in environmental fate, ecotoxicological and toxicological profile (refer to the endpoint discussion for further details). The selected studies are thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Read-across justification
Data on the acute dermal toxicity of Esterification product of glycerol and C8-C12 (even numbered) fatty acids (old CAS 26402-22-2) are not available. The assessment of acute dermal toxicity was therefore based on a study conducted with a source substance as part of a read across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Acute oral toxicity
CAS 91052-13-0
The acute oral toxicity of Glycerides, C8-18 and C18-unsatd. mono- and di-, acetates, was assessed in a study performed according to OECD guideline 423 and under GLP conditions (Key, 2010). A total of 3 female Wistar rats were exposed to a limit dose of 2000 mg/kg bw in a stepwise procedure (3 rats per step). No mortality was observed up to the end of the 14-day observation period. Hunched posture and/or piloerection were noted in all females on Day 1 of the observation period. All animals showed the expected gain in body weights during the study and necropsy revealed no substance-related findings. Based on the results, the oral LD50 value for female Sprague Dawley rats is > 2000 mg/kg bw. In accordance with OECD guideline 423, the oral LD50 cut-off of the test substance is considered to be 5000 mg/kg bw.
CAS 142-18-7
The acute oral toxicity of 2,3-dihydroxypropyl laurate was investigated in Wistar rats according to the national FDA guideline "Appraisal of the safety of chemicals in foods, drugs and cosmetics" (Key, 1977). In this experiment, 2 groups of 5 animals per sex and dose were administered the test material in the vehicle (corn oil) by gavage at doses of 10,000 and 20,000 mg/kg bw, respectively. One of the 5 males and 1/5 female treated with 20,000 mg/kg bw died 48 h after test substance administration. No mortality was observed at 10,000 mg/kg bw during the 7-day observation period. At both dose levels, slight staggering, ataxia and piloerection were observed 1 and 3 h post-administration (number of animals not specified). The observed clinical signs were reversible within 24 h. Body weight gains were reduced in the surviving males and females of the 20,000 mg/kg bw group from Day 0 to Day 7. This effect was mainly attributed to a strong decrease in body weight in 1/4 males and 1/4 females at study termination (ca. -11 and -28%, respectively). The body weight gain of the remaining 3 animals per sex ranged from 4 to 7% (males) and 10 to 19% (females). The body weight gain of male and female animals treated with 10,000 mg/kg bw was within the normal range for this species and strain. The mean group body weight gain was about 14 and 18% for males and females, respectively. Necropsy revealed no substance-related findings in the examined organs (brain, lung, heart, stomach, intestine, liver, spleen, kidneys, serous membrane/vessels, lymph nodes and gonads). Based on the results, the oral LD50 value for male and female Wistar rats is > 20,000 mg/kg bw.
CAS 73398-61-5
The acute oral toxicity of Triglycerides, mixed decanoyl and octanoyl was investigated in Tyler's Original Strain mice in an early study similar to OECD guideline 401 (Key, 1977). Ten female animals per dose were gavaged with the undiluted test substance at volumes of 12.5, 20 and 25 mL/kg bw, which were equivalent to doses of 11,812.5, 18,900 and 23,625 mg/kg bw as calculated from a density of 0.945 g/mL. Mortality was observed within 24-48 h in animals receiving the test substance at 20 and 25 mL/kg bw (number of dead animals not reported). Ataxia, lethargy, dyspnoea and diuresis were observed within 15 min of treatment. Complete loss of activity was observed in several animals within 2 h after administration, although other individuals were found to become more active at this time. All survivors appeared asymptomatic from Day 3 up to the end of the study period. Some individuals showed a slight loss in body weight at Day 7. Based on these results, the oral LD50 value for female Tyler's Original Strain mice was determined to be > 23,625 mg/kg bw.
Overall conclusion for acute toxicity
The reliable data available for the three source substances indicate a very low level of acute oral toxicity, as LD50 values were greater than the currently applied limit values. The LC50 value was the maximum attainable concentration. Therefore, as the available data did not identify any hazard for acute toxicity, Esterification product of glycerol and C8-C12 (even numbered) fatty acids is not expected to be hazardous following acute exposure.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Esterification product of glycerol and C8-C12 (even numbered) fatty acids (no CAS) data will be generated from information available on reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
Therefore, based on the analogue read-across approach, the available data on acute toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.